Stryker’s disclosures highlight its proactive maintenance of performance under challenging conditions through a long-term capital allocation strategy that prioritizes acquisitions, dividends and share repurchases, supplemented by operating cash flow and, as necessary, debt financing to fund operations, capital expenditures and strategic investments. Management underscores its ability to generate substantial cash from operations and to readily access capital markets at competitive rates despite heightened inflationary pressures from global supply chain disruptions, labor shortages, higher interest rates, fluctuating foreign currency exchange rates and geopolitical conflicts, reflecting an organizational focus on liquidity management, economic factors and tax considerations. The company employs non-GAAP financial measures—excluding items not indicative of core operating results—as baseline indicators for trend analysis, budgeting and incentive compensation, and anticipates meeting short-term liquidity needs through cash from operations, commercial paper, existing credit lines and a revolving credit agreement maturing in October 2026. In response to a slower-than-anticipated recovery in its spine reporting unit, rising costs and competitive pressures, Stryker performed a quantitative impairment test and recorded a $216 million goodwill impairment charge in 2022, thereafter reconfiguring valuation assumptions and confirming at October 31, 2023 that fair value continued to exceed carrying amounts by 10%. The company further reviews long-lived assets for indicators of impairment based on undiscounted cash flows and market appraisals. Stryker records reserves for legal matters and uncertain income tax positions based on the best estimate of probable losses and adjusts such estimates as circumstances evolve, illustrating robust risk assessment and mitigation mechanisms. Across its operations, the company invests in product launches, compliance with evolving medical device regulations, supply chain efficiencies and pricing and volume adjustments to offset higher raw material costs and supply chain inefficiencies, thereby preserving or improving functioning and partial integrity in the face of external pressures.